Johnson & Johnson Revenue 2010-2024 | JNJ

Johnson & Johnson revenue for the twelve months ending September 30, 2024 was $87.696B, a 14.92% increase year-over-year.

  • Johnson & Johnson annual revenue for 2023 was $85.159B, a 6.46% increase from 2022.
  • Johnson & Johnson annual revenue for 2022 was $79.99B, a 1.59% increase from 2021.
  • Johnson & Johnson annual revenue for 2021 was $78.74B, a 4.65% decline from 2020.

Johnson & Johnson Revenue 2010-2024 | JNJ

  • Johnson & Johnson annual revenue for 2023 was $85.159B, a 6.46% increase from 2022.
  • Johnson & Johnson annual revenue for 2022 was $79.99B, a 1.59% increase from 2021.
  • Johnson & Johnson annual revenue for 2021 was $78.74B, a 4.65% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$690.3B
Novo Nordisk (NVO)$447.9B
AbbVie (ABBV)$293.8B
Merck (MRK)$244.3B
Novartis AG (NVS)$210.6B
AstraZeneca (AZN)$196.5B
Pfizer (PFE)$140.9B
Sanofi (SNY)$123.1B
Innoviva (INVA)$1.2B